#United States #Pittsburgh #Health Innovations #Nanomedicine Lab #Duquesne University

Duquesne University's Nanomedicine Lab: Transforming Healthcare with Tiny Particles

In the heart of Pittsburgh, the Duquesne University Nanomedicine Manufacturing Laboratory (NML) is making significant strides in the field of health science by harnessing the potential of nanotechnology. Under the leadership of Dr. Jelena Janjic, an Associate Professor of Pharmaceutics, the lab is pioneering innovative approaches to tackle major health issues, particularly in pain relief and organ transplantation.

Revolutionizing Pain Management

The NML has gained recognition as a trailblazer in the creation of nanomedicines designed specifically for trauma and surgical pain relief. This groundbreaking development has the potential to significantly reduce the reliance on opioids, paving the way for safer recovery options for patients. By utilizing tiny particles, the lab is transforming how medical professionals manage pain after surgeries, showcasing a paradigm shift towards more effective and responsible pain management strategies.

Enhancing Organ Preservation and Transplantation

Beyond pain relief, the Nanomedicine Lab has also embarked on ventures aimed at revolutionizing organ preservation techniques. One of their notable achievements is the development of an oxygen carrier integrated with imaging clinical-grade agents that enable real-time monitoring during organ and limb preservation processes. This technology not only aims to minimize organ rejection risks but may also enhance the overall success rates of organ transplantation procedures, which remains a pressing global health concern.

A Collaborative Approach to Whole Eye Transplants

The NML’s expertise was recognized on a larger scale when they engaged with over 40 scientists, physicians, and industry specialists for an ambitious initiative—the Transplantation of Human Eye Allografts (THEA) program, backed by a $56 million funding grant from the Advanced Research Projects Agency for Health (ARPA-H). With prominent leaders like Dr. Jeffrey Goldberg from Stanford University leading the program, the NML’s involvement is pivotal, highlighting their capacity to deliver on multiple fronts in this groundbreaking project.

Dr. Janjic expressed her enthusiasm for the collaborative effort, noting that Duquesne is unique in receiving two sub-proposer contracts within the project. "Our innovative nanomedicines play a crucial role in imaging tissue responses during rejection episodes and in evaluating immunosuppression treatments. Moreover, we provide effective methods for organ preservation and targeted drug delivery, critical components for transplantation success," she remarked.

Ensuring Quality in Nanomedicine Production

A key aspect of the success of the Nanomedicine Lab lies in its quality-by-design manufacturing process, which underscores their commitment to creating cost-effective and reliable nanoscale therapeutics. Traditional nanotechnology approaches often grapple with high costs and quality control challenges; however, the NML has distinguished itself by being capable of producing large quantities—multiliter volumes—of complex, patent-protected nanomedicine formulations across diverse applications, from pain alleviation to organ preservation.

In addition to their work with organ preservation, the lab recently secured a $1.5 million grant from the U.S. Department of Defense to further their research in applying nanoparticle technology to facilitate limb preservation. These funding accomplishments not only underscore the increasing recognition of their pioneering research but also highlight the lab’s significant role in advancing healthcare solutions.

Looking Ahead

The ongoing projects and newfound collaborations at the Duquesne Nanomedicine Manufacturing Laboratory exemplify the institution’s commitment to pushing the boundaries of science and technology for the betterment of society. By addressing critical health challenges through nanomedicine, the lab is not only benefiting researchers and students but also making strides that promise to enhance patient care and outcomes in the broader healthcare landscape. As the field of nanomedicine continues to evolve, Duquesne University stands out as a beacon of innovation and hope in solving some of medicine’s most pressing dilemmas.